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Abstract 
Chromobodies have recently drawn great attention as bioimaging nanotools. They offer 
antigen binding specificity and affinity comparable to conventional antibodies, but much 
smaller size and higher stability. Importantly, chromobodies can be used in live cell imaging 
for highly specific spatio-temporal visualization of cellular processes. To date, functional 
application of chromobodies requires lengthy genetic manipulation of the target cell. Here, we 
developed multifunctional large-pore mesoporous silica nanoparticles (MSNs) as nanocarriers 
to directly transport chromobodies into living cells for antigen-visualization in real time. The 
multifunctional large-pore MSNs feature high loading capacity for chromobodies (70 µg 
chromobody/mg MSNs), and are efficiently taken up by cells (after 2 h of incubation with 
chromobody-loaded MSNs (MSN-Ca-Cbs) more than 90 % of the cells have taken up the 
MSN-Ca-Cbs). By functionalizing the internal MSN surface with nitrilotriacetic acid-metal 
ion (NTA-M2+) complexes, we could control the release of His6-tagged chromobodies from 
MSNs in acidified endosomes. When chromobodies escape from the endosomes through the 
proton sponge effect generated by their built-in His6-tags, co-localization of signals from 
fluorescent endogenous antigen and organic dye-labeled chromobodies can be detected. The 
successful chromobody delivery signals can be observed even at very low effective 
concentrations of chromobodies introduced to the incubation solution. Various endosomal 
release triggers (fusogenic peptide INF7, acid shock, DMSO, chloroquine) were further 
examined to enhance the endosomal release of chromobodies. The results showed that short 
incubation with DMSO or chloroquine with MSN-Ca-Cb pretreated cells at room temperature 
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results in a 12 – 18 fold increase of chromobody release efficiency. Hence, by combining the 
two nanotools, chromobodies and MSNs, we established a new powerful approach for 
chromobody applications in living cells. 
Introduction 
Today, antibodies are considered to be the most powerful tools for specific visualization 
of cellular compartments at the molecular level aimed at the study of cellular processes. They 
are indispensable for proteomic analyses, protein localization and detection of 
posttranslational modifications. However, the application of full-length antibodies is restricted 
to fixed, meaning dead cells, since the massive sizes (~ 150 kD) and complex folding 
structures including intermolecular disulphide bridges limit their use in living cells via the 
transient expression approach or via direct delivery. As a result, the idea of engineering 
recombinant small antibodies for real time dynamic protein tracing in living cells has received 
much attention. A variety of recombinant small antibodies including immunoglobulin (Ig) 
derived Fab (~ 50 kD) and scFv (~ 25 kD), as well as non-Ig derived monobody (~ 10 kD) 
and affibody (~ 6.5 kD) protein scaffolds have been generated in the last decades for this 
purpose[1]. Nanobodies (~ 14 kD) are the single-domain antigen-binding fragments derived 
from camelid’s single-chain IgG[2]. They have a binding affinity and specificity similar to 
conventional antibodies, but are much smaller in size and exhibit higher stability. When 
conjugated with fluorescent proteins or organic dyes, the fluorescent nanobodies, named 
chromobodies, become molecular probes that can trace the dynamics of endogenous cellular 
structures in living cells. Chromobodies have successfully shown their antigen detection 
efficacy on cytoskeleton, histone protein and DNA replication complexes, and have revealed 
the spatio-temporal protein changes during cell cycles[3]. In our previous report[4], HIV-
specific chromobodies have been generated and used for real time visualization of HIV 
assembly in living cells. These studies demonstrate that chromobodies are promising protein 
reporters for the study of cellular processes in living cells. However, to date the application of 
chromobodies for live cell imaging was limited due to the need to introduce them genetically, 
followed by subsequent cytosolic expression. To broaden the flexibility and use of 
chromobodies in biomedical applications (e.g., manipulation of cell function for disease 
treatment), direct intracellular delivery of the molecular probes would be highly desirable. 
However, intracellular protein delivery is challenging firstly because the large size of proteins 
leads to difficulties with passive diffusion through the cell membrane or with endocytosis. 
The following endosomal trapping of internalized proteins further limits the protein functions 
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in cells. A few studies of non-carrier intracellular protein delivery aimed to enhance the 
cellular uptake efficiency in combination with endosomolytic agents and therefore to increase 
the protein delivery efficacy[5, 6]. For example, Erazo-Oliveras et al. co-incubated dimerized 
cell-penetrating peptide TAT (dfTAT) with proteins (EGFP and Cre recombinase, etc.) in 
culture media, the results show that proteins were successfully crossing the cell membrane 
with the help of dfTAT and presenting their functions in cytosols[5]; D’Astolfo et al. used 
hyperosmolality NaCl buffer to induce the high efficient micropinocytosis of proteins. In 
combination with a transduction compound (a propanebetaine), intracellcular release was 
achieved[6]. Alternatively, using carriers such as cationic polyplexes with high cellular uptake 
efficiency for proteins may improve the generally low efficiency of protein uptake. However, 
the complex structures and wide variety of surface charges of proteins make it difficult to 
design a general carrier for universal protein delivery[7]. The second challenge of protein 
delivery is that proteins are susceptible. Proteins must maintain their tertiary structure to 
preserve their functionality during the delivery process.   
To address these bottlenecks, we surmised that mesoporous silica nanoparticles (MSNs) 
could be promising candidates for serving as efficient and versatile protein delivery vehicles. 
For example, their surface can be modified with different functionalities and charges to 
accommodate different proteins; their pore sizes are tunable to fit different cargo sizes; their 
framework is stable and can effectively protect cargos from environmental degradation, and 
they can be efficiently taken up by cells. In the past years, the development of MSNs for 
biomedical applications has greatly increased. The achievements include delivery of 
chemotherapeutic agents for cancer therapy [8], intracellular protein delivery for manipulation 
of cell function[9, 10], and oligonucleotide delivery for gene therapy[11, 12]. These studies 
demonstrate that MSNs can efficiently control the release of cargos in the target tissue/cells as 
well as effectively protect cargos from degradation. Importantly, MSNs were found to be 
biocompatible within certain concentration ranges[13].  
In this study, we synthesized multifunctional large-pore MSNs for intracellular 
chromobody delivery. Metal chelate complexes were covalently attached on the internal silica 
surface and used for pH-responsive coordination binding of His6-tagged chromobodies. The 
binding affinity and pH-stimulated release of various metal ions (Fe2+, Co2+, Ni2+, Cu2+, Zn2+ 
and Ca2+) with His6-tagged chromobodies were examined by colorimetric measurements in 
vitro. Mouse embryonic fibroblasts (MEFs) expressing EGFP fused to LMNA (an inner 
nuclear membrane protein) (MEF-G-LMNA) were generated for the detection of GFP-
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specific chromobody release and function in intracellular delivery experiments. The 
successful chromobody delivery, release from the endosomes and binding to the target 
structures could be confirmed by the fluorescence co-localization signals of EGFP and 
chromobodies on the LMNA structure. 
Results and Discussion 
Synthesis and characterization of large-pore MSN 
Mercapto-functionalized MSNs (MSN-SH) were synthesized using a sol-gel templating 
approach in a neutral pH reactive solution according to a modified protocol from the 
literature[14]. During the synthesis process (Figure 1a) the structure directing agent 
cetyltrimethylammonium (CTA+) formed micelles in the initial solution, silica precursors 
TEOS and MPTES were then adsorbed and co-condensed around the micelles because of the 
electrostatic attraction between CTA+ and negatively charged silica. In this neutral pH 
synthesis solution, the counter ions Tos- compete with the silicate oligomers for association 
with the positively charged micelles, which results in sparse silica condensation and 
consequently the large stellate pore structure formation (Figure 1b)[14]. Mercapto-functional 
groups were introduced homogeneously into the silica framework via cocondensation for the 
purpose of further functionalization. According to the N2 sorption analysis (Figure 1c), MSN-
SH has a fairly wide pore size distribution from 10 nm to 20 nm, a BET surface area of 
670 m2/g and a large pore volume of 3.06 cm3/g. With these pore dimensions, chromobodies 
featuring a size of 2 nm x 4 nm[15] are expected to be efficiently loaded into the mesopores. 
The hydrodynamic particle size (Figure 1d) measured by DLS was 100 – 200 nm. This 
particle size range is considered to be favorable for endocytosis[16]. 
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Figure 1. Synthesis and characterization of MSN-SH. (a) MSN-SH was synthesized through a modified 
protocol described earlier in the literature[14]. MSN-SH was synthesized by co-condensation of oligosilicates 
(from TEOS) and mercapto-functionalized oligosilicates (from MPTES) in a neutral pH reaction mixture. (b) 
TEM image of MSN-SH. The high contrast areas indicate the dense silica backbones whereas the low contrast 
areas indicate the pore structure. The average particle size is about 100 nm according to the TEM image. (c) 
Nitrogen sorption isotherm (outer figure) of MSN-SH and its corresponding pore size distribution (inner figure) 
calculated by the NLDFT mode based on the adsorption branch of N2 on silica. (d) Dynamic light scattering 
(DLS) of hydrodynamic particle size of MSN-SH in EtOH. The average hydrodynamic particle size is around 
160 nm. 
NTA-metal ion complex modified MSNs for controlled uptake and release of 
chromobodies 
To control chromobody loading and release from the silica framework, nitrilotriacetic acid 
-metal ion complexes (NTA-M2+) were attached to the MSN surface as pH-responsive linkers. 
The recombinant GFP-specific chromobody possesses a built-in His6-tag on its C-terminus for 
purification purposes. This His6-tag can be used as a tether to conjugate chromobodies onto 
NTA-M2+ complexes because there are three potential coordination sites on the histidine 
molecule: the carboxyl group (pKa = 1.9), the imidazole nitrogen (pKa = 6.1) and the amino 
nitrogen (pKa = 9.1). Among these coordination sites, the imidazole nitrogen is considered to 
be the primary site for the conjugation with metal ions. The conjugation can be separated by 
high imidazole concentration buffer elution (free imidazole substitutes the coordination 
binding of histidine on the NTA-M2+ complexes). Alternatively, low pH buffer can also be 
used for elution since the imidazole nitrogen is protonated under acidic conditions (pH < 6) 
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and therefore acidification results in the detachment of His6-tagged chromobodies from NTA-
M2+ complexes. 
To carry out the MSN modification, MSN-SH was converted to carboxyl-functionalized 
MSN (MSN-COOH) by reacting MSN-SH with 6-maleimidohexanoic acid in ethanol. The 
MSN-COOH was then conjugated with Nα,Nα-bis(carboxymethyl)-L-lysine hydrate (NTA-
lysine) via an EDC-sulfo NHS coupling approach (Figure 2a). The 1700 cm-1 peak attributed 
to a C=O vibration in the IR spectrum (Figure 2b, red line) indicated the successful coupling 
of 6-maleimidohexanoic acid with MSN-SH, while the conjugation of MSN-COOH and 
NTA-lysine was verified by the increased secondary amide bond signal at 1650 cm-1 in the IR 
spectrum (Figure 2b, blue line). After this two-step modification, the final NTA-conjugated 
MSNs (MSN-NTA) still exhibit the desired large-pore structure as well as colloidal stability 
(Figure S1). To compare the effect of different NTA-M2+ complexes for His6-tagged 
chromobody conjugation, various metal ions: Fe2+, Co2+, Ni2+, Cu2+, Zn2+ and Ca2+ were 
immobilized onto MSN-NTA, yielding NTA-M2+-complex-modified MSNs (MSN-M2+) 
(Figure 2c). Chromobodies were then loaded on the MSN-M2+ carriers (MSN-Fe2+, MSN-
Co2+, MSN-Ni2+, MSN-Cu2+, MSN-Zn2+ and MSN-Ca2+) as well as MSN-SH (as control 
group) in 0.05 M Tris-acetate buffer (pH 8). Subsequently, chromobody loading and release 
tests were performed via measurements of the fluorescence intensity (emission at 669 nm) of 
the loading/release supernatants. The fluorescent intensity of a dilution series of pure 
chromobodies was measured as standard curve for the following quantification. Based on the 
results shown in Figure 2d, all samples (MSN-Fe2+, MSN-Co2+, MSN-Ni2+, MSN-Cu2+, 
MSN-Zn2+, MSN-Ca2+ and MSN-SH; for the latter, see discussion below) exhibited a 
similarly high chromobody loading capacity of approximately 70 µg/mg MSN. This loading 
capacity corresponds to about 600 chromobody molecules per MSN. After incubation of the 
chromobody-loaded MSNs (MSN-M-Cb) in pH 7 buffer for 16 h, all the samples showed on 
average only 5 % release of the loaded chromobodies (Figure 2e). However, performing the 
chromobody release in pH 5 buffer, MSN-Ni2+, MSN-Cu2+, MSN-Zn2+ and MSN-Ca2+ 
exhibited significantly higher chromobody release efficiency than in pH 7 (Figure 2e). In 
general, the extent of release of His6-tagged proteins from the NTA-M2+ moieties is 
determined by two factors: (i) the stability of the metal chelation by NTA, and (ii) the stability 
of the coordination between metal ions and histidine molecules. The general stability order of 
NTA-metal ion and histidine-metal ion complexes is: 
Cu2+ > Ni2+ > Zn2+ > Co2+ > Fe2+ > Ca2+[17, 18]. The results shown here indicate that 
Cu2+, Ni2+, Zn2+ and Ca2+ are able to allow for the chromobody release in an acidic 
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environment at pH 5, while Cu2+, Ni2+ and Zn2+ show a rather high stability when 
incorporating to the MSN-NTA system. By contrast, Co2+ and Fe2+ showed no significant 
differences of chromobody controlled release in pH 7 and pH 5 buffers due to their weak 
complexing stability with either NTA or histidine. Interestingly, although the coordination 
stability of NTA-Ca2+ is low, His6-tagged chromobodies still bind sufficiently to MSN-Ca2+ in 
pH 7 buffer. Practically, MSN-Ca2+ is favored for chromobody delivery because the 
decomposition of the NTA-Ca-chromobody complex starts already at pH 6 (data not shown), 
therefore more chromobodies can be released in the early endosome stage. Moreover, small 
amounts of Ca2+ are considered to be biocompatible and non-toxic.  
 
Figure 2. Surface modification of MSN and chromobody (atto 647N labeled) controlled release test in vitro. 
(a) Modification process of MSN-SH to yield MSN-NTA. (b) IR spetra of the functionalized MSNs during each 
modification step. MSN-SH (black), MSN-COOH (red) and MSN-NTA (blue). (c) MSN-NTA particles were 
treated with different metal ion solutions (50 mM), respectively, at room temperature for 6 h. The free metal ions 
were then washed away with water, and the resulting metal-immobilized MSNs (MSN-M2+) were incubated with 
chromobody loading buffers (100 µg chromobody/ml in Tris-acetate buffer, pH 8) at 4 ⁰C for 2 h to bind the 
chromobodies to MSNs. (d) Chromobody loading capacity of different metal-immobilized MSNs. MSN-SH 
served as control group in the in vitro controlled release test. (e) Chromobody loaded MSN particles (MSN-M-
Cb) were dispersed in PBS buffer (with pH 7 or pH 5) at 37 ⁰C for 16 h. Afterwards, the supernatants were 
collected and the amounts of chromobody released were measured using colorimetric analysis. Pure 
chromobodies were diluted in PBS buffer at different concentrations for creating the standard curve. Error bar: 
standard error. 
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The control group MSN-SH particles showed high chromobody loading capacity and low 
chromobody release in both pH 7 and pH 5 even without any capping system or chemical 
conjugation. This indicates that the negatively charged silica framework (zeta potential: -13.7 
mV at pH 5, -30.8 mV at pH 7) exhibits non-specific binding to chromobodies. The MSN-
M2+ carriers we developed here are not only useful for His6-tagged chromobody controlled 
release, but also promising for universal His-tagged protein delivery to living cells. Several 
groups have previously shown the successful binding and release of His-tagged proteins on 
NTA-Ni2+ complex modified silica substrates either for protein delivery or for biosensor 
detection[9, 10, 19]. Similarly, these proteins could be attached to the large internal surface of 
our MSN-M2+ carrier system. 
MSN-Ni2+, MSN-Zn2+ and MSN-Ca2+ (primary carrier) were used for the following 
intracellular chromobody delivery study in MEF-G-LMNA cells. To address possible 
concerns of cytotoxicity of the dissociated metal ions after uptake of the particles into the 
cells, we performed MTT assays after incubation of MSN-Ni2+, MSN-Zn2+ and MSN-Ca2+ 
particles with the MEF cells (wild type) for 24 h. The results (Figure S2) indicate that these 
three metal-immobilized MSNs, as well as un-functionalized MSNs are non-toxic to MEF 
cells below a concentration of 100 µg/ml. 
Cellular uptake of MSNs 
After the study of chromobody loading and release from NTA-M2+ complex modified 
MSNs, we further investigated the interactions between cells and MSNs. There are numerous 
studies about the cellular uptake of nanoparticles (e.g. liposomes, polyplexes and silica 
nanoparticles, etc.)[16, 20-27]. These studies reveal that electrostatic surface charge of 
nanoparticles, functionalization, particle shape and particle size are key factors that can affect 
the endocytosis mechanisms. For example, positively charged nanoparticles are favored for 
cellular uptake because the negatively charged cell membrane tends to attract the positively 
charged particles on its surface; particle sizes below 200 nm are considered the most 
favorable size for cellular internalization. In addition, the endocytosis behavior for different 
nanoparticles is also dependent on cell-type[28, 29]. In this study, the MSN size used for 
intracellular chromobody delivery is about 100 – 200 nm. The endocytosis pathways are 
mostly clathrin-mediated or caveolin-mediated endocytosis[16, 27]. The confocal images in 
Figure 3a reveal the kinetics of cellular uptake of chromobody loaded-MSNs (MSN-Ca-Cbs) 
by MEF-G-LMNA cells. MSN-Ca-Cbs were added to the cells in serum free medium at a 
concentration of 5 µg/ml, and real-time live cell images at the indicated time points were 
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acquired. As the incubation time increased, the number of MSN-Ca-Cbs co-localized with 
cells also increased. After 2 h of co-incubation with MSN-Ca-Cbs, almost all cells in the 
imaging frame co-localized with more than two MSN-Ca-Cbs. High content statistics of 
cellular uptake of MSN-Ca-Cbs for different time points and concentrations were examined 
with a high throughput imaging system (Operetta®, PerkinElmer). Different concentrations of 
MSN-Ca-Cb (5 µg/ml, 10 µg/ml and 20 µg/ml) were added to each sample in a 24-well plate. 
At the indicated time points, cells were washed to remove free MSN-Ca-Cbs, and were then 
imaged by Operetta immediately. On average 600 cells were imaged and analyzed per sample. 
The evaluation sequence is shown in the supplementary information (Figure S3). The results 
(Figure 3b and 3c) from the high content analysis illustrate that cellular uptake of MSN-Ca-
Cbs is time and dose dependent. After 10 min of incubation, more than 30 % of the cells have 
taken up MSN-Ca-Cbs already (cells with more than two MSN-Ca-Cb spots within their 
cytosols and nuclear region are defined as MSN-uptake cells; each MSN-Ca-Cb spot might 
contain more than one MSN-Ca-Cb) both for low particle concentration (5 µg/ml) and for 
high particle concentration (20 µg/ml). After 2 h of incubation with MSN-Ca-Cbs, more than 
90 % of the cells have taken up MSN-Ca-Cbs. This result demonstrates the high cellular 
uptake efficiency of MSN-Ca-Cbs by MEF-G-LMNA cells.  
To further visualize the MSN locations in the cytosol we used super-resolution 
microscopy (3D SIM). A stable MEF cell line (MEF-mEGFP) that expresses endogenous 
membrane co-localizing EGFP protein was developed to label the cell boundary. Cy3 labeled 
MSNs (MSN-Cy3) at the concentration 10 µg/ml were incubated with MEF-mEGFP cells on 
a glass coverslip in culture medium for 2 h. Afterwards, cells were washed to remove free 
MSNs and were fixed. DAPI counterstaining was performed after cell fixation. The super 
resolution microscope image (Figure 3d, XY view and XZ cross-section view) visually 
confirms that MSNs were internalized by MEF-mEGFP cells. The image clearly shows that 
the internalized MSN-Cy3s were equally distributed in the cytosol, and single particles can be 
seen in the magnified images.   
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Figure 3. Cellular uptake of MSNs. (a) Real-time live cell imaging of the MSN-Ca-Cb uptake process by 
MEF-G-LMNA cells. Images were taken at the indicated time points after incubation with MSN-Ca-Cb (5 µg/ml) 
on MEF cells in a 2-well ibidi cell culture slide. Scar bar: 20 µm. (b), (c) Time-based analyses of cellular uptake 
of MSN-Ca-Cb using a high-throughput imaging system (Operetta®, PerkinElmer). Cells were seeded on 24-well 
plates at the concentration of 3 × 104 cells/well and incubated at 37 ⁰C overnight. Cell culture medium was 
removed and different concentrations of MSN-Ca-Cb particles in serum free DMEM (phenol red free) were then 
added to each well. After incubation of MSN-Ca-Cb particles with cells for the indicated time intervals, free 
particles were removed by washing with PBS, and high-throughput live cell imaging was performed.  
Experiments were triplicated. An average of 600 cells were imaged in each experiment. Error bar: standard 
deviation. (d) Super-resolution microscopy (3D SIM) image of a cell after MSN internalization. Cy3-labeled 
MSNs (10 µg/ml) were incubated with MEF-mEGFP cells (MEF cells which stably express EGFP on their 
plasma membrane) (3 × 105 cells/well) on a glass coverslip in a 6-well plate for 2 h. Afterwards, free MSNs were 
removed by washing with PBS. Cells were then fixed with 3.7 % formaldehyde and counterstained with DAPI 
(1 µg/ml in PBS). Green: EGFP, red: Cy3 labeled MSNs, magenta: DAPI counterstaining. Scale bar: 5 µm for 
main figure and XZ cross-section figure, 1 µm for magnified figures. 
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Intracellular chromobody delivery  
In the intracellular chromobody delivery experiment we used MSN-Ca2+ as the main 
chromobody carrier. Above we have shown that the average chromobody loading capacity in 
MSN-M2+ is 70 µg/mg MSN (Figure 2c). Here we added the MSN-Ca-Cbs to the cell culture 
slide (µ-Slide 2-well, ibidi) at a concentration of 5 µg/ml (1 ml of culture medium per well), 
which yields a chromobody concentration for the intracellular delivery of approximately 25 
nM. Importantly, compared to the recently published papers of direct protein delivery that use 
micromolar protein concentrations in each experiment, the amount of cargo we used in this 
work is 200 times less[5, 6]. MEF-G-LMNA cells were used to detect the release and function 
of GFP-specific chromobodies. When Atto 647N labeled GFP-specific chromobodies are 
delivered to and subsequently released from endosomes, they passively diffuse through the 
nuclear envelope and bind to GFP molecules on the LMNA structure. Therefore, a distinct 
microscopic co-localization signal from EGFP-LMNA and GFP-specific chromobodies can 
be observed. Figure 4 illustrates the successful delivery of GFP-specific chromobodies to 
MEF-G-LMNA cells.  After 24 h of incubation with MSN-Ca-Cbs, several cells can be 
observed with chromobody release. In fact, chromobody release can already be seen after 4 h 
incubation of MSN-Ca-Cbs in some cells, and the chromobody staining remained on the 
EGFP-LMNA structure until 96 h after incubation (Figure S4). We also examined two other 
carriers: MSN-Ni2+ and MSN-Zn2+, and both of them allowed for intracellular chromobody 
delivery (Figure S4). To systematically quantify the efficiency of chromobody delivery via 
MSNs, we then used a high-throughput imaging system to image a large quantity of cells and 
further calculate the chromobody release efficiency (chromobody release 
efficiency % = chromobody stained cells/GFP-LMNA-positive cells x 100 %). The result 
(Figure 5a, the control group) showed only 1 – 2 % chromobody release efficiency after 24 h 
post MSN-Ca-Cbs incubation. We attribute the low release efficiency to endosomal trapping 
of most of the internalized particles, whereas the limited observed endosomal escape of 
chromobodies might result from the proton sponge effect generated by the His6-tag on 
chromobodies.   
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Figure 4. Live cell confocal imaging of intracellular chromobody delivery. 24 h post incubation of MSN-Ca-
Cbs (5 µg/ml) with MEF-G-LMNA cells. Scale bar: 10 µm. Representative images are presented. 
 
To enhance endosomal release, we investigated 4 different endosomal escape triggers: 
fusogenic peptide INF7, acid shock, DMSO and chloroquine. 
Fusogenic peptide INF7 is a peptide derivative from influenza virus hemagglutinin HA2 
protein. Wagner et al. first reported in 1994 that the 23 N-terminal amino acid sequence of 
HA2 has liposome disruption ability and erythrocyte lysis activity[30]. The derivative INF7 
peptide exhibits more pH specificity with membrane disruption ability and erythrocyte lysis 
activity than HA2 due to its conformation change in acidic environment. Therefore, this pH-
dependent conformation change and membrane-disruptive fusogenic peptide is promising for 
endosomal escape since the late endosomes feature an acidic environment at ~ pH 5. Here, we 
conjugated the INF7 peptide to MSNs using a pH-responsive acetal linker [31](Figure S5), 
then co-incubated MSN-INF7s with MSN-Ca-Cbs to MEF-G-LMNA cells for 2 h. However, 
the result (Figure 5a) showed that INF7 has no enhancement for the chromobody delivery 
efficiency. The second endosomal release trigger we used here is acid shock, that is, 
extracellular acidification of cells. The purpose of using acid shock is to generate external 
stress on cells and to investigate if the cellular stress response is to increase the endosomal 
leakage. However, the acid shock applied in this experiment had no effect on the chromobody 
delivery efficiency. Moreover, the acidic buffer incubation leads to 60 % cell death 
(Figure 5b). The third endosomal release trigger DMSO has been reported to be capable of 
enhancing membrane permeability[32-35]. A molecular dynamics simulation demonstrated 
that DMSO molecules can cause fluctuations on the two hydrophilic sides of the lipid bilayer 
followed by the formation of a water-permeable pore in the lipid bilayer[34]. Wang et al. used 
it to enhance the penetration efficiency of the cell-penetration peptide TAT fusion protein[35]. 
In our study a short incubation (5 – 10 min) with 7 % DMSO indeed enhances the release of 
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chromobodies from the endosomes. The chromobody release efficiency increased from 1 % 
(control group) to 12 % after this short incubation with DMSO (Figure 5a). Furthermore, the 
increased endosomal release of chromobodies can be detected right after the DMSO treatment 
(data not shown).  
The most effective endosomal release trigger studied in this work is chloroquine. 
Chloroquine is a well-known lysosomotropic agent (and anti-malaria drug) that preferentially 
accumulates in lysosomes and destabilizes the lysosomal membrane. When chloroquine is 
used at low concentration, it increases the pH of the acidic endosomes[36]. When applied at 
high concentration (> 100 µM), chloroquine can generate a strong proton sponge effect and 
therefore destabilize the endosomal membrane[37]. Our study shows that a short incubation of 
high concentration (500 µM) chloroquine facilitates endosomal release. In contrast to the 
DMSO treatment, the proton-sponge effect for increased endosomal release becomes obvious 
24 h after the chloroquine treatment. To sum up the endosomal escape experiments, INF7 and 
acid shock showed no increase of chromobody release efficiency (same as the control group, 
1 – 2 %) while cells treated with DMSO or chloroquine showed 12 – 18 fold increase in 
efficiency. The corresponding live cell images of increased chromobody release efficiency 
after treatment with DMSO and chloroquine are shown in Figure 5d. 
Since the introduction of endosomal triggers might induce cytotoxicity, we analyzed cell 
viability after each endosomal trigger treatment. The cultured cells were imaged before MSN-
Ca-Cbs incubation, and the numbers of GFP-LMNA-positive cells were counted. After 2 h 
incubation of MSN-Ca-Cbs in serum-free medium and following the treatment with 
endosomal release triggers, cells were imaged and counted again. The blank group refers to 
cells incubated in serum-free medium for 2 h without MSN-Ca-Cb treatment and no 
endosomal trigger treatment. Cell viability was calculated based on: GFP-LMNA-positive 
cells after drug treatment/GFP-LMNA-positive cells before MSN-Ca-Cb treatment x 100 %. 
The cell viability analysis shown in Figure 5b indicates that, compared to the blank group and 
the control group, the short exposure to 7 % DMSO or 500 µM chloroquine has almost no 
effect on cell viability. The slight decrease in cell viability of the blank group, control group, 
DMSO-treated cells and chloroquine-treated cells might result from the serum free medium 
incubation. Cell proliferation was also studied after endosomal trigger treatment to ensure the 
drug treatment has no effect on cell proliferation. The result in figure 5c indicated that DMSO 
and chloroquine treated cells proliferate normally in the following days.   
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Figure 5. Comparison of different endosomal release triggers for chromobody delivery efficiency. High-
throughput imaging system (Operetta®, PerkinElmer) was used for chromobody delivery efficiency (a), cell 
viability (b) and cell proliferation (c) studies. (a) Chromobody delivery efficiency after treatment with different 
endosomal release triggers. 24 h after MSN-Ca-Cb incubation and endosomal release trigger treatment, cells 
were imaged by Operetta. GFP-positive cells were counted by Harmony software, and chromobody-stained cells 
were counted visually. Chromobody delivery efficiency % = chromobody-stained cells/GFP--positive cells x 100 
%. (b) Cell viabilities after treatment with different endosomal release triggers. Cells were imaged by Operetta 
before MSN-Ca-Cbs incubation. After 2 h incubation of MSN-Ca-Cbs and short treatment with different 
endosomal release triggers, cells in the same region of each plate were then imaged with Operetta again. Cell 
viability % = GFP-positive cells after drug treatment/ GFP-positive cells before drug treatment x 100 %. (c) Cell 
proliferations after treatment with different endosomal release triggers. The cell number immediately after drug 
treatment of each sample is defined as 1-fold. Cell numbers were then counted every 24 h by Operetta. (a), (b), 
(c) Experiments were triplicated. Error bar: standard deviation. (d) Live cell confocal images of intracellular 
chromobody delivery after non-treatment (control), DMSO-, and chloroquine-treated MEF-G-LMNA cells. 
Scale bar: 20 µm. 
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Conclusion 
In this work, we successfully developed NTA-metal ion modified MSNs as carriers for 
intracellular chromobody delivery. We systematically studied (1) the interactions between 
His6-tagged chromobodies and NTA-M2+ modified MSNs; (2) cellular uptake of MSNs, and 
(3) endosomal release triggers for the enhancement of chromobody release efficiency. MSN-
Ca2+, MSN-Ni2+ and MSN-Zn2+ carriers all are applicable for successful intracellular 
chromobody delivery, while DMSO and chloroquine are effective triggers for drastically 
increased chromobody release efficiency. We could clearly demonstrate the functionality of 
the delivered chromobodies based on their specific binding to GFP-LMNA. Thus, the 
mesoporous MSN-M2+ carriers can now enable the direct delivery of chromobodies into cells 
to image and understand biological processes. Moreover, we envision that the novel delivery 
strategy based upon the MSN-M2+ carriers can be generalized toward the cellular delivery of 
other His-tagged proteins aimed at various biological applications.  
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Supporting information 
Experimental section 
Materials 
Tetraethyl orthosilicate (TEOS, Aldrich, ≥ 99 %), (3-mercaptopropyl)triethoxysilane 
(MPTES, Aldrich, ≥ 80 %), cetyltrimethylammonium p-toluenesulfonate (CTATos, Sigma), 
triethanolamine (TEA, Aldrich, 98 %), bi-distilled water is obtained from a Millipore system 
(Milli-Q Academic A10). 6-Maleimidohexanoic acid (Aldrich), N(alpha),N(alpha)-
bis(carboxymethyl)-L-lysine hydrate (NTA-lysine, Aldrich), N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide (EDC, Alfa-Aesar, 98 %), N-hydroxysulfosuccinimide sodium salt (sulfo-
NHS, Aldrich), iron (II) chloride tetrahydrate (Sigma Aldrich), cobalt (II) chloride 
hexahydrate (Aldrich), nickel chloride hexahydrate (Riedel-de Haen), copper chloride 
dihydrate (LMU), zinc chloride (Aldrich), calcium chloride dihydrate (LMU), magnesium 
chloride (Aldrich), tris(hydroxymethyl)-aminomethane (TRIS, ≥ 99 %, ROTH, 2449), acetic 
acid (99 % - 100 %, ROTH, 7332), thiazolyl blue tetrazolium bromide (MTT, ≥ 97.5 %, 
Sigma, M5655), dimethyl sulfoxide molecular biology grade (DMSO, Applichem, A3006), 3-
Maleimidopropionic acid N-hydroxysuccinimide ester (99 %, Sigma Aldrich), 3,9-Bis(3-
aminopropyl)-2,4,8,10-tetraoxaspiro[5.5]undecane (AK linker, Tokyo Chemical Industry), 
formaldehyde solution (37 %, Applichem), SSC buffer 20x (Sigma), Dulbecco’s Modified 
Eagle’s Medium (DMEM, Sigma, D6429), Dulbecco’s Phosphate Buffered Saline (PBS, 
Sigma, D8537), FBS Superior (Biochrom, S0615), Gentamycin solution (SERVA, 50 mg/ml), 
trypsin-EDTA solution (Sigma, T3924), Dulbecco’s Modified Eagle’s Medium – phenol red 
free (DMEM, Sigma, D1145), L-glutamine solution (200 mM, Sigma, G7513), HEPES 
solution (1 M, Sigma, H3537). 
MSN synthesis and modification 
The MSN-SH was synthesized following a modified recipe reported earlier[14]. In brief, 
TEA (47 mg, 0.32 mmol), CTATos (0.263 g, 0.58 mmol) and H2O (13.7 g, 0.77 mmol) were 
mixed in a 100 ml glass flask and vigorously stirred (1250 rpm) at 80 ⁰C until the solution 
became homogeneous. A mixture of TEOS (1.8 g, 8.64 mmol) and MPTES (0.23 g, 
0.96 mmol) was then added and the solution was continuously stirred (1250 rpm) at 80 ⁰C for 
2 h. Afterwards the reaction solution was cooled down to room temperature under ambient 
conditions, and the particles were collected by centrifugation (43146 x g, 20 min). The 
organic template extraction was carried out right after the particle collection. The particle 
20 
	  
pellet was re-suspended in an ethanolic solution (100 mL) containing 2 g of ammonium 
nitrate, and the solution was heated to 90 ⁰C under reflux for 1 h. The second template 
extraction step was subsequently performed by heating the particles under reflux at 90 ⁰C in 
an ethanolic solution (100 mL) containing 10 mL of hydrochloric acid (37 %). The MSN-SH 
was collected by centrifugation (43146 x g, 20 min) and was washed with water and EtOH 
after each extraction step.  
The template-extracted MSN-SH was then modified to yield NTA-functionalized MSN 
(MSN-NTA). 60 mg of MSN-SH and 30 mg (0.142 mmol) of 6-maleimidohexanoic acid were 
mixed in 12 ml of EtOH. The mixture was stirred at room temperature overnight. The 
resulting MSN-COOH particles were collected by centrifugation (43146 x g, 20 min), washed 
twice with EtOH and re-dispersed in 12 ml of EtOH. The amount of 40 mg of MSN-COOH in 
8 ml of EtOH was then mixed with EDC (15 µl, 67.5 µmol) at room temperature for 10 min. 
Sulfo-NHS (14.6 mg, 67.5 µmol) and NTA-lysine (17.5 mg, 67.5 µmol) were mixed in 1 ml 
of H2O and afterwards added to the MSN solution. The mixture was stirred at room 
temperature for 2 h, and the resulting MSN-NTA particles were washed twice with H2O and 
EtOH to remove the residual chemicals. 20 mg each of MSN-SH, MSN-COOH and MSN-
NTA were dried for further characterization. 
Characterization of MSN 
Transmission electron microscopy (TEM) was performed at 200 kV on a Jeol JEM-2010 
instrument with a CCD detection system. A drop of diluted MSN suspension was dried on a 
carbon-coated copper grid at room temperature for several hours before TEM observation. 
Nitrogen sorption measurements were performed on a Quantachrome Instrument NOVA 
4000e at 77 K. Samples (about 15 mg) were degassed at 120 ⁰C under vacuum (10 mTorr) for 
12 h before measurement. The pore volume and pore size distribution were calculated based 
on non-local NLDFT procedures provided by Quantachrome, using the adsorption branch 
ofN2 on silica. The hydrodynamic sizes of MSNs were measured by dynamic light scattering 
(DLS) analysis using a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne 
laser (633 nm). Infrared spectra of different organic functional groups on MSNs were 
recorded on a Thermo Scientific Nicolet iN10 IR-microscope in reflection-absorption mode 
with a liquid-N2 cooled MCT-A detector.  
Generation of GFP-specific chromobody 
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GFP-specific nanobody expression was performed in E. coli (JM109). Expression was 
induced with 0.5 mM IPTG, and cells were incubated at 37 °C for 24 h. Cells were lysed in 
the presence of lysozyme (100 µg/ml), DNAse (25 µg/ml) and PMSF (2 mM) followed by 
sonication (Branson® Sonifier; 16 x 8 sec, 20 % Amplitude) and debris centrifugation at 
20000 x g for 30 min. Protein purification was performed with an Äkta FPLC system (GE 
Healthcare, USA) using a 5 mL His-Trap  column (GE Healthcare, USA); peak fractions were 
concentrated to 2 ml using Amicon filter columns (cut-off 10 kDa, Merck Millipore, Germany) 
followed by size exclusion chromatography using a Superdex 75 column (GE Healthcare, 
USA). Peak fractions were pooled and protein aliquots were shock-frozen and stored at -
80 °C. 1 mg purified nanobody protein was then labeled with Atto 647N (AttoTec, Germany) 
with a theoretical DOL (degree of labeling) of 3, according to the manufacturers’ instructions. 
Unbound dye was removed by gel filtration in PD10 columns (GE Healthcare, USA). The 
final Atto 647N labelled GFP-specific chromobody was obtained and preserved in PBS in the 
concentration of 1 mg/ml. 
Chromobody loading and release in vitro test 
MSN-NTA (200 µg/vial, 6 vials) was treated with 50 mM solutions of different metal ions 
(0.5 mL each) (FeCl2, CoCl2, NiCl2, CuCl2, ZnCl2 or CaCl2) at room temperature for 6 h. 
After metal ion immobilization, the excess un-bound metal ions were washed out with 3 ml of 
H2O. 200 µg of each NTA-M2+-complex-modified MSNs (MSN-M2+) was then suspended in 
150 µl of chromobody loading buffer where the concentration of chromobody was 100 µg/ml 
in 0.05 M Tris-acetate buffer (pH 8.0), and incubated at 4 °C for 2 h. The un-bound 
chromobodies were then removed by centrifugation (4218 x g, 3 min) and the chromobody-
loaded MSNs (MSN-M-Cbs) were washed 3 times (1 ml per wash) with 0.05 M Tris-acetate 
buffer (pH 8.0). Centrifugation (4218 x g, 3 min) was applied in every wash step to separate 
the supernatant and particles. Before the buffer release experiments, each type of MSN-M-
Cbs was separated into two vials holding equal amounts (100 µg MSN/vial). Subsequently, 
150 µl of PBS having different pH values (pH 7 and pH 5) were added to suspend the MSN-
M-Cbs (100 µg). The in vitro chromobody release experiments were performed at 37 °C for 
16 h. The solutions with released chromobody were centrifuged (4218 x g, 3 min) and then 
the supernatants were collected. The final chromobody release supernatants were quantified 
via their fluorescence intensity at 669 nm (excitation 644 nm) in a 96-well plate (Greiner Bio-
One, Germany) by a microplate reader (Infinite® M1000 PRO, TECAN, Switzerland). The 
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quantification was based on a calibration curve with a series of diluted pure chromobody 
solutions. 
Cell culture and stable cell lines 
MEF cells were cultured in DMEM medium supplemented with 10 % FBS and 50 µg/ml 
gentamycin under 5 % CO2 at 37 °C (cell culture medium). 
The plasmid construction for stable cell line generation was performed as follows. The 
plasmid pmEGFP-N1 was constructed by cloning of membrane EGFP [38] into pEGFP-N1 
vector (Clontech) with AgeI and BsrGI endonucleases (Thermo Fisher Scientific) to substitute 
the EGFP with mEGFP. To prepare the pCAG-eG-LMNA-IB plasmid, the mouse LmnA/C 
gene was amplified with primers (forward primer: 5’-GGG CGA TCG CAT GGA GAC CCC 
GCT ACA and reverse primer: 5’-AGT CGC GGC CGC TTT ACA TGA TGC TGC) by 
PCR and cloned into plasmid under a CAG promoter with AsisI and NotI restriction sites. 
To make the GFP-LMNA expression cell line, pCAG-eG-LMNA-IB was transfected into 
MEF cells with Lipofectamine 2000 reagent (Invitrogen), and positive cells (MEF-G-LMNA) 
were selected with 6 µg/ml blasticidin (Sigma) for two weeks then sorted with a fluorescence-
activated cell sorting (FACS) Aria II (Becton Dickinson) instrument. For the mEGFP 
expression cell line, pmEGFP-N1 was transfected into MEFs, and mEGFP stable expression 
cells (MEF-mEGFP) were purified by FACS two weeks after transfection. 
Sample preparation for cellular uptake experiments of MSNs  
Live cell imaging medium (LCIM) containing DMEM – phenol red free, FBS (10 %), L-
glutamine (200 µM), HEPES (20 mM) and gentamycin (50 µg/ml) was used for cell 
incubation in all live cell microscopy experiments. 
For real-time tracing of cellular uptake of MSN-Ca-Cbs, MEF-G-LMNA cells were 
seeded on a 2-well µ-Slide (ibidi, Germany) in 50 % confluence (the proportion of the culture 
slide surface which is covered by cells) for overnight incubation. In each culture well, 1 ml of 
culture medium or LCIM was used for either cell culture or microscopy. 5 µg/ml of MSN-Ca-
Cb in serum-free LCIM was added to cells and images were acquired at 10 min, 20 min, 30 
min, 1 h and 2 h after the addition of MSN-Ca-Cbs.  
For the high content live cell imaging, MEF-G-LMNA cells were plated on 24-well plates 
(Corning, USA) in 70 % confluence. The working volume for all kinds of solution (cell 
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culture medium, PBS, etc.) in the 24-well plate is 0.5 ml per well.  MSN-Ca-Cb with different 
concentrations (5 µg/ml, 10 µg/ml and 20 µg/ml) in serum free DMEM were added to cells. 
At indicated time points (10 min, 20 min, 30 min, 1 h and 2 h), cells were washed with PBS 
three times to remove residual MSN-Ca-Cbs in the medium. CellMaskTM orange (Thermo 
Fisher Scientific) (5 mg/ml in DMSO) was diluted 1000x in LCIM and incubated with cells at 
37 ⁰C for 10 min for plasma membrane staining. After the plasma membrane staining, the 
CellMask solution was removed. LCIM was then added to the sample and high content 
imaging was performed immediately. 
For the super-resolution microscopy (3D SIM), MEF-mEGFP cells were cultured on an 
18 x 18 mm coverslip in a 6-well plate (Corning, USA) (3 × 105 cells/well). 10 µg/ml of Cy3 
(Lumiprobe, Germany)-labelled MSNs (MSN-Cy3) in 2 ml of serum free DMEM were added 
to cells and incubated for 2 h. Cells were then washed with PBS three times to remove 
residual MSNs, followed by fixation using 3.7 % of formaldehyde in PBS (10 min in room 
temperature). DAPI (1 µg/ml in PBS) counterstaining (10 min in room temperature) was 
performed after cell fixation. The sample was then mounted in Vectashield antifade mounting 
medium (Vector Laboratories, USA) to a glass slide.  
Intracellular chromobody delivery - sample preparation 
MEF-G-LMNA cells in cell culture medium were seeded on either a 2-well µ-Slide (1 
ml/well) or a 24-well plate (0.5 ml/well) in 50 % confluence one day before the intracellular 
chromobody delivery experiment. The applied culture medium or LCIM volume in each well 
(1 ml/well for 2-well µ-Slide; 0.5 ml/well for 24-well plate) is the same for all following 
intracellular delivery experiment. MSN-Ca-Cbs, MSN-Ni-Cbs and MSN-Zn-Cbs were 
prepared in serum-free DMEM culture media at a concentration of 5 µg/ml, respectively. The 
culture medium was removed from the pre-seeded cells followed by the addition of pre-mixed 
MSN-M-Cb containing medium. The MSN-M-Cbs were incubated with cells at 37 °C for 2 h. 
Afterwards, the residual particles in the medium were washed out by PBS, and the cells were 
incubated in LCIM for the following live cell imaging processes.   
   Experiments with samples treated with endosomal triggers were carried out according to 
two different approaches. MSN-Ca2+ was the main carrier used in the following experiments. 
For the INF7 treatment, INF7 peptide (Biosyntan GmbH) was conjugated on MSNs with pH-
responsive acetal linkers as indicated in Figure S5. In brief, 10 mg (37 µmol) of 3-
(Maleimido)propionic acid N-hydroxy succinimide (dissolved in 100 µl of DMSO) and 6 mg 
24 
	  
(22 µmol) of AK linker (dissolved in 1 ml of 1x SSC buffer, pH 7.4) were mixed at room 
temperature and stirred for 1 h. 5 mg of MSN-SH in stock solution (20 mg/ml in EtOH) was 
collected by centrifugation (16837 x g, 5 min) and re-suspended in previous solution. The 
mixture was stirred at room temperature overnight. The resulting MSN-AK-linker particles 
was collected by centrifugation (16837 x g, 5 min) and washed by H2O (10 ml/wash, 3 times 
wash).  INF7 peptide consisting cysteine on its C-terminus was conjugated to 1 mg of MSN-
AK-linker particle with a content of 10 INF7 molecules per MSN in 1 ml of DMSO. The 
mixture was stirred at room temperature for 1 h and the final MSN-INF7 particles were 
washed with 1 ml of DMSO two times. MSN-INF7s (1 µg/ml) and MSN-Ca-Cbs (5 µg/ml) 
were co-incubated with MEF-G-LMNA cells in serum free cell culture medium for 2 h. The 
residual particles in the incubation medium were afterwards washed out by PBS (1 ml/well). 
The MSN-INF7 and MSN-Ca-Cb treated cells were then incubated in LCIM for live cell 
imaging. For the acid shock treatment, DMSO and chloroquine release trigger tests, PBS (pH 
6), 7 % DMSO in LCIM and 500 µM chloroquine in LCIM were introduced to MSN-Ca-Cb-
treated cells and incubated at room temperature for 5 – 10 min. The release trigger solutions 
were then removed from the cells, and cells were then incubated in LCIM for live cell 
imaging. 
Optical microscopy 
Spinning Disc 
MSN-M-Cb-treated cells plated on 2-well µ-Slide were selected and imaged in LCIM. 3D 
stacks were acquired with an UltraVIEW Vox spinning disc confocal system (PerkinElmer, 
UK) in a closed live cell microscopy chamber (ACU control, Olympus, Japan) heated to 37 
°C, with 5 % CO2 and 60 % humidified atmosphere, mounted on a Nikon Ti microscope 
(Nikon, Japan). Image acquisition was performed using either 63x/1.4 NA or 40x/1.3 NA 
Plan-Apochromat oil immersion objective lenses. Images were obtained with a cooled 14-bit 
EMCCD camera (C9100-50, CamLink) with a frame size of 1024 x 1024 pixels. GFP and 
fluorophores were excited with 488 nm (10 % power density), 561 nm (5 % power density) or 
647 nm (30 % power density) solid-state diode laser lines.  
 
Operetta 
High-throughput images of living cells on a 24-well plate (3 × 104 cells/well) were 
acquired automatically with an Operetta high content imaging system (PerkinElmer, UK). 
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Imaging was performed using a 40× air objective lens. GFP, CellMask and chromobody-
atto647N were excited and the emissions were recorded using standard filters. The exposure 
time was controlled at 200 – 400 ms to avoid pixel saturation, and 50 different fields were 
imaged in each well. In the cellular uptake experiment, on average 600 cells were imaged. 
The images were then analyzed by the Harmony analysis software (PerkinElmer) with a 
sequence as described in Figure S3. In the endosomal release trigger, cell viability and cell 
proliferation analyses, MEF-G-LMNA cells before any treatment were first imaged and 
counted. After addition of MSNs and the following endosomal release triggers treatment, cells 
were imaged and counted again. The definition of cell viability % is: GFP-LMNA-positive 
cells after endosomal release trigger treatment/GFP-LMNA-positive cells before any 
treatment × 100 %. The blank group refers to the cells incubated in serum-free DMEM culture 
medium for 2 h without MSN and endosomal release trigger treatment. Control group refers 
to the cells incubated with MSN-Ca-Cbs for 2 h, but no endosomal release trigger treatment 
afterwards. Chromobody release efficiency was recorded 24 h after MSN-Ca-Cbs introduction. 
Cells exhibiting a chromobody release signal were counted visually. The chromobody release 
efficiency is defined as: chromobody-LMNA-positive cells/GFP-LMNA-positive cells × 
100 %. Cells with different treatments were imaged and counted every 24 h for the cell 
proliferation calculation. 400 to 10000 cells were imaged in the endosomal release trigger, 
cell viability and cell proliferation tests depending on the recording time point.        
Super-resolution microscopy (3D-SIM) 
Super-resolution microscopy (3D-SIM) was performed with a Delta Vision OMX v3 
(Applied Precision, GE Healthcare) instrument equipped with 405 nm, 488 nm and 593 nm 
laser diodes, a 100×/1.4 NA Plan-Apochromat oil immersion objective lens (Olympus) and 
Cascade II:512 EMCCD cameras (Photometrics). The image stacks were acquired with a z-
step of 125 nm and with 15 images per plane (five phases, three angles). The raw data were 
computationally reconstructed by using the SoftWorx 5.1.0 software.  
MTT assay 
MEF cells (wild type) were first seeded on 96-well microplates with the concentration of 
5 × 103 cells/well in cell culture medium (100 µl/well), and incubated at 37 °C for 16 h. 
MSNs (un-MSNs, MSN-Ni2+, MSN-Zn2+, MSN-Ca2+) (2 mg from stock solution) in EtOH 
were centrifuged down (16873 x g, 5 min), and re-suspended in cell culture medium at the 
concentration of 1 mg/ml. The MSN solutions were then series diluted to the desired particle 
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concentrations. After removal of the culture medium, 100 µl of MSN solution with different 
concentrations was added to each well. Also, 100 µl of cell culture medium was added to cells 
to serve as control group. The wells with 100 µl of cell culture medium but without cells were 
referred to as blank groups. MSN solutions and cells were then co-incubated at 37 °C 
overnight. Afterwards, the MSN-treated cells were washed with PBS buffer three times to 
remove the residual particles. MTT was diluted in cell culture medium at the concentration of 
0.5 mg/ml and then added to the cells (100 µl/well). After incubating the MTT solution and 
cells for 4 h, purple crystals metabolized by healthy cells were observed. Subsequently, 
100 µl of pure DMSO was added to each well and the samples were incubated at 37 °C for 
1 h until the purple crystals were dissolved. The absorbance at 570 nm and the reference 
absorbance at 655 nm were measured on each sample using a Microplate reader (Infinite® 
M1000 PRO, TECAN).  
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Supplementary figures 
 
Figure S1. Characterization of NTA-conjugated MSNs (MSN-NTA).  (a) Nitrogen sorption isotherm, (b) 
pore size distribution and (c) DLS analysis (particles suspended in EtOH) indicated that MSN-NTA preserved 
the large-pore mesoporosity and colloidal stability after surface modification. 
 
 
Figure S2. Cytotoxicity tests (MTT assay) of different metal-treated MSN-NTA samples (MSN-Ni2+, MSN-
Zn2+ and MSN-Ca2+) and un-functionalized MSN (un-MSN) on MEF cells (wild type). All the particle types 
show no significant cytotoxicity below the particle concentration of 100 µg/ml. 
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Figure S3. High throughput imaging evaluation of cellular uptake of MSN-Ca-Cbs. MEF-G-LMNA living 
cells were stained with CellMask orange and imaged at indicated time points after the addition of MSN-Ca-Cbs. 
Fluorescence from GFP, CellMask orange, and Atto 647N (labeled on chromobodies) were recorded separately 
with Operetta high content image analysis system using standard filter for 488 nm, 546 nm and 647 nm emission. 
Images were analyzed with Harmony analysis software as the following sequence. (a) The nuclear region is 
segmented from the background according to GFP-LMNA signal where the GFP-LMNA signal is shown in grey 
and the circular color lines stand for the segmentation results. Most of the recognized nuclear region fit the GFP-
LMNA signal, which indicates a correct segmentation. (b) The cytoplasm region was recognized via CellMask 
signal segmentation. The cytoplasm region is obtained by subtraction of nuclear region obtained from step (a). 
The border of the segmented cell region was shown as closed color lines around the nuclear region. (c) 
Recognition of MSN-Ca-Cbs taken up by the cells. Internalized MSN-Ca-Cbs were visualized as spots within 
the cytoplasm region, and the spots recognition was presented as color dots in the image. The segmented results 
(nuclei, cytoplasm and MSN-Ca-Cb spots) were used to define populations. Population 1: Cell = GFP-LMNA 
nucleus plus its surrounding cytoplasm region. Population 2: MSN-uptake cell = cell with more than two MSN-
Ca-Cb spots in its cytoplasm and nucleus region. The evaluation results were based on the calculation: (i) % cell 
take up MSN-Ca-Cbs = MSN-uptake cells/total cells; (ii) average MSN-Ca-Cb spots per MSN-uptake cell = 
total spots number in all MSN-uptake cells/MSN-uptake cells. 
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Figure S4. Intracellular delivery of chromobodies via different metal-treated MSNs. (a) 4 h after MSN-Ni-
Cb/MSN-Zn-Cb/MSN-Ca-Cb incubation. (b) 96 h after MSN-Ni-Cb/MSN-Zn-Cb/MSN-Ca-Cb incubation. 
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Figure S5. Conjugation of INF7 peptide to MSNs via pH-responsive acetal linker. MSN-SH was conjugated 
with pH-responsive acetal linker (3,9-bis(3-aminopropyl)-2,4,8,10-tetraoxaspiro-[5,5]-undecane) (AK linker) via 
the maleimide-NHS heterobifunctional crosslinker (3-Maleimidopropionic acid NHS ester) yielding MSN-AK-
linker. INF7 peptide consisting of cysteine on its C-terminus was covalently attached to MSN-AK-linker through 
the maleimide-thiol reaction.	  
 
